Abbvie Inc (NYSE:ABBV) shares traded -0.52% lower at $205.19 on Wall Street last session.
ABBV stock price is now 3.00% away from the 50-day moving average and 9.45% away from the 200-day moving average. The market capitalization of the company currently stands at $362.98B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On December 05, 2024, Daiwa Securities Downgraded its previous ‘Outperform’ rating to ‘Neutral’ on the stock keeping its target price maintained at $180, while ‘Leerink Partners’ rates the stock as ‘Outperform’
In other news, Stewart Jeffrey Ryan, EVP, CHIEF COMMERCIAL OFFICER sold 58,832 shares of the company’s stock on Mar 31 ’25. The stock was sold for $12,359,504 at an average price of $210.08. Upon completion of the transaction, the EVP, CHIEF COMMERCIAL OFFICER now directly owns 53,234 shares in the company, valued at $10.92 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 31 ’25, Officer Stewart Jeffrey Ryan bought 58,832 shares of the business’s stock. A total of $12,359,897 was incurred on buying the stock at an average price of $210.09. A total of 0.11% of the company’s stock is owned by insiders.
During the past 12 months, Abbvie Inc has had a low of $153.58 and a high of $218.66. As of last week, the company has a debt-to-equity ratio of 20.40, a current ratio of 0.66, and a quick ratio of 0.55. According to the stock market information, the enterprise value for the company is $426642735104, which is based on a 85.80 price-to-earnings ratio, a 5.59 price-to-earnings-growth ratio, and a beta of 0.54. The fifty day moving average price for ABBV is $199.2044 and a two-hundred day moving average price translates $187.4714 for the stock.
The latest earnings results from Abbvie Inc (NYSE: ABBV) was released for 2024-12-31. The net profit margin was 7.52% and return on equity was 61.94% for ABBV. The company reported revenue of $15.1 billion for the quarter, compared to $14.3 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.6 percent.
